Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
Asunto de la revista
Intervalo de año de publicación
1.
J Korean Med Sci ; 38(16): e129, 2023 Apr 24.
Artículo en Inglés | MEDLINE | ID: mdl-37096312

RESUMEN

BACKGROUND: Alpha-toxin (AT), a major virulence factor of Staphylococcus aureus, is an important immunotherapeutic target to prevent or treat invasive S. aureus infections. Previous studies have suggested that anti-AT antibodies (Abs) may have a protective role against S. aureus bacteremia (SAB), but their function remains unclear. Therefore, we aimed to investigate the association between serum anti-AT Ab levels and clinical outcomes of SAB. METHODS: Patients from a prospective SAB cohort at a tertiary-care medical center (n = 51) were enrolled in the study from July 2016 to January 2019. Patients without symptoms or signs of infection were enrolled as controls (n = 100). Blood samples were collected before the onset of SAB and at 2- and 4-weeks post-bacteremia. Anti-AT immunoglobin G (IgG) levels were measured using an enzyme-linked immunosorbent assay. All clinical S. aureus isolates were tested for the presence of hla using polymerase chain reaction. RESULTS: Anti-AT IgG levels in patients with SAB before the onset of bacteremia did not differ significantly from those in non-infectious controls. Pre-bacteremic anti-AT IgG levels tended to be lower in patients with worse clinical outcomes (7-day mortality, persistent bacteremia, metastatic infection, septic shock), although the differences were not statistically significant. Patients who needed intensive care unit care had significantly lower anti-AT IgG levels at 2 weeks post-bacteremia (P = 0.020). CONCLUSION: The study findings suggest that lower anti-AT Ab responses before and during SAB, reflective of immune dysfunction, are associated with more severe clinical presentations of infection.


Asunto(s)
Bacteriemia , Infecciones Estafilocócicas , Humanos , Staphylococcus aureus , Estudios Prospectivos , Formación de Anticuerpos , Bacteriemia/tratamiento farmacológico , Infecciones Estafilocócicas/tratamiento farmacológico , Inmunoglobulina G , Antibacterianos/uso terapéutico
3.
Int J Neurosci ; 114(5): 575-85, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15204064

RESUMEN

Dopamine cells derived from neural stem cells were transplanted into the dopamine-denervated striatum in the rat. Survival of the dopamine cells, gliosis, and immunological reaction were examined by immunostaining. Tyrosine hydroxylase immunoreactive (TH+) cells were seen in the needle tract, walls of the lateral ventricle, thalamus, hippocampus, and external and internal capsules for up to 3 weeks examination. Most TH+ cells had mature-looking polygonal shapes with processes. Some cells migrated into the striatum. Behavioral improvement was not seen


Asunto(s)
Movimiento Celular/fisiología , Dopamina/metabolismo , Neuronas/trasplante , Enfermedad de Parkinson/patología , Células Madre/fisiología , Adrenérgicos/toxicidad , Animales , Conducta Animal , Encéfalo/citología , Encéfalo/metabolismo , Diferenciación Celular/fisiología , Supervivencia Celular/fisiología , Modelos Animales de Enfermedad , Embrión de Mamíferos , Factores de Crecimiento de Fibroblastos/fisiología , Inmunohistoquímica/métodos , Proteínas de Filamentos Intermediarios/metabolismo , Masculino , Actividad Motora/fisiología , Proteínas del Tejido Nervioso/metabolismo , Nestina , Neuronas/metabolismo , Oxidopamina/toxicidad , Enfermedad de Parkinson/etiología , Enfermedad de Parkinson/terapia , Ratas , Ratas Sprague-Dawley , Trasplante de Células Madre/métodos , Tirosina 3-Monooxigenasa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA